본문 바로가기
카테고리 없음

Last year, the domestic pharmaceutical market is close to 30 trillion won…The highest level of all time -South Korea News

by The Korea News Translator 2023. 8. 2.

Last year, the domestic pharmaceutical market is close to 30 trillion won…The highest level of all time -South Korea News




The first place in the production performance 'Corona 19 White', the first place in the production of quasi -drugs 'Bacchus' production performance 1 trillion company, Modera Korea, Celltrion, Hanmi Pharm, Chong Kun Dang



Oh Yu -kyung, head of the Food and Drug Administration, is looking at the acetaminophen manufacturing process at the Cheonan Cheonan Plant in Cheonan, Chungcheongnam -do on the afternoon of the afternoon.2023.1.5/News1 (Seoul = News1) Reporter Kang Seung -ji = In 2022, the domestic pharmaceutical market amounted to 29.8595 billion won with 30 trillion won.After surpassing 25 trillion won for the first time in 2021, it rewritten the highest level ever.In particular, biopharmaceutical production and export performance recorded the highest level, and Corona 19 treatment and vaccines still accounted for pharmaceutical production and imports..In 2021, it grew 17.6% from 25.393 trillion won.The size of the pharmaceutical market is measured by adding the amount of pharmaceutical production and imports and the amount of imports.



Provided) "Pharmaceutical Production of 28.95 trillion won… Bio's production of bio drugs."This accounts for 1.4%of the gross domestic product (GDP) and 5.2%of the domestic manufacturing industry.In the last five years, the average annual growth rate is 8.2%, which is four times the average annual growth rate (2.2%) in the domestic manufacturing industry.) There are four companies, including Hanmi Pharm (1 trillion won) and Chong Kun Dang (1.59 trillion won).Subsequently, there are Green Cross (814.7 billion won), Daewoong Pharm (7787 billion won), HKiinoen (7727 billion won), and LG Chemical (751.8 billion won).The company recorded 10.45 trillion won, down 8% from before.The growth of biopharmaceuticals is noticeable.Bio's production results were estimated at KRW 5,412.7 billion, up 14.2% from 4,739.8 billion won in 2021.Bio's drug production has grown at an average annual growth rate of 20% in the last five years.Bio's exports also recorded 3.6 trillion won ($ 2.78 trillion), up 75.5% from 2021 due to biosimilar exports and the production of Corona 19 -year -olds, and the import of Corona 19th, which reached 7.11 trillion won in 20121 last year, last year.It has been reduced to 5.16 trillion won for the first time in the last five years.Despite the decrease in imports, the corona 19 -year -olds have been ranked No. 1 in the market for two years.In terms of import performance, the top of the production and import performance of vaccines was the corona 19 -year -old and treated drugs in 2022, following 2021.Complete drug production performance was the first and second place in the corona 19 -year -old Modera Korea's 'Spa Echox Box' and 'Spa Echobox 2 weeks' respectively.Gilead Science Korea 'Beckleuri beer -use frozen is the order of Korean painting and pharmaceutical' cominati 2 weeks', and Modera Korea 'Moderas Pike Box 2 weeks' was in the order.It was high in the order of analgesic and anti -inflammatory drugs, and the KORONA 19 would be caused by increasing demand for drugs to relieve symptoms, and the KFDA said.Jinhae expectorant production increased 134.2% to 244.2 billion won, antipyretic, analgesic and anti -inflammatory drugs increased by 48.6% to 504.6 billion won.It was revealed to an increase of 3.37 trillion won.The production amount of professional drugs increased by 13.5% to 21.986.4 billion won.The % decreased to 2.13 trillion won.However, the production of quasi -drugs other than the quarantine goods grew 5.4%.Among the top five items of quasi -drug production, masks accounted for 33%, and last year, the number of quasi -drug producers and items was 1113 and 5909, respectively, down 15.9%and 7.4%from the same period.By item, Dong -A Pharm 'Bacchus Dye' was ranked first for three years, followed by the same company Bacchus F liquid and Donghwa Pharmaceuticals.Yuhan Kimberly, AMOREPACIFIC, and LG Nii Cham followed.These companies accounted for 35.5%of the total production of quasi -drugs.

https://n.news.naver.com/mnews/article/421/0006959843?sid=101